These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26230577)

  • 1. Reactivity and Speciation of Anti-Diabetic Vanadium Complexes in Whole Blood and Its Components: The Important Role of Red Blood Cells.
    Levina A; McLeod AI; Gasparini SJ; Nguyen A; De Silva WG; Aitken JB; Harris HH; Glover C; Johannessen B; Lay PA
    Inorg Chem; 2015 Aug; 54(16):7753-66. PubMed ID: 26230577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivity-activity relationships of oral anti-diabetic vanadium complexes in gastrointestinal media: an X-ray absorption spectroscopic study.
    Levina A; McLeod AI; Kremer LE; Aitken JB; Glover CJ; Johannessen B; Lay PA
    Metallomics; 2014 Oct; 6(10):1880-8. PubMed ID: 25100248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformations of Antidiabetic Vanadium Prodrugs in Mammalian Cells and Cell Culture Media: A XANES Spectroscopic Study.
    Levina A; McLeod AI; Pulte A; Aitken JB; Lay PA
    Inorg Chem; 2015 Jul; 54(14):6707-18. PubMed ID: 25906315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
    Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
    Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of antidiabetic vanadium compounds with hemoglobin and red blood cells and their distribution between plasma and erythrocytes.
    Sanna D; Serra M; Micera G; Garribba E
    Inorg Chem; 2014 Feb; 53(3):1449-64. PubMed ID: 24437949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biospeciation of various antidiabetic V(IV)O compounds in serum.
    Jakusch T; Hollender D; Enyedy EA; González CS; Montes-Bayón M; Sanz-Medel A; Costa Pessoa J; Tomaz I; Kiss T
    Dalton Trans; 2009 Apr; (13):2428-37. PubMed ID: 19290378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel V(IV)O-pyrimidinone complex: synthesis, solution speciation and human serum protein binding.
    Gonçalves G; Tomaz I; Correia I; Veiros LF; Castro MM; Avecilla F; Palacio L; Maestro M; Kiss T; Jakusch T; Garcia MH; Pessoa JC
    Dalton Trans; 2013 Sep; 42(33):11841-61. PubMed ID: 23677414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanadium(V) and -(IV) complexes of anionic polysaccharides: Controlled release pharmaceutical formulations and models of vanadium biotransformation products.
    Kremer LE; McLeod AI; Aitken JB; Levina A; Lay PA
    J Inorg Biochem; 2015 Jun; 147():227-34. PubMed ID: 25958254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray absorption near-edge structure micro-spectroscopy study of vanadium speciation in Phycomyces blakesleeanus mycelium.
    Žižić M; Dučić T; Grolimund D; Bajuk-Bogdanović D; Nikolic M; Stanić M; Križak S; Zakrzewska J
    Anal Bioanal Chem; 2015 Sep; 407(24):7487-96. PubMed ID: 26253227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
    Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
    Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of potential anti-diabetic molybdenum(VI) complexes in biological media: a XANES spectroscopic study.
    Levina A; McLeod AI; Seuring J; Lay PA
    J Inorg Biochem; 2007 Nov; 101(11-12):1586-93. PubMed ID: 17764745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of insulin-enhancing properties of vanadium-dipicolinate complexes in model membrane systems: phospholipid langmuir monolayers and AOT reverse micelles.
    Sostarecz AG; Gaidamauskas E; Distin S; Bonetti SJ; Levinger NE; Crans DC
    Chemistry; 2014 Apr; 20(17):5149-59. PubMed ID: 24615733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mononuclear and dinuclear monoperoxovanadium(v) complexes with a hetero ligand. 1.(1) Self-decomposition reaction, detection of reactive oxygen species, and oxidizing ability.
    Kanamori K; Nishida K; Miyata N; Shimoyama T; Hata K; Mihara C; Okamoto K; Abe Y; Hayakawa S; Matsugo S
    Inorg Chem; 2004 Nov; 43(22):7127-40. PubMed ID: 15500351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique dinuclear mixed V(V) oxo-peroxo complex in the structural speciation of the ternary V(V)-peroxo-citrate system. potential mechanistic and structural insight into the aqueous synthetic chemistry of dinuclear V(V)-citrate species with H2O2.
    Kaliva M; Gabriel C; Raptopoulou CP; Terzis A; Voyiatzis G; Zervou M; Mateescu C; Salifoglou A
    Inorg Chem; 2011 Nov; 50(22):11423-36. PubMed ID: 22029259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilities and Biological Activities of Vanadium Drugs: What is the Nature of the Active Species?
    Levina A; Lay PA
    Chem Asian J; 2017 Jul; 12(14):1692-1699. PubMed ID: 28401668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new dinuclear Ti(IV)-peroxo-citrate complex from aqueous solutions. Synthetic, structural, and spectroscopic studies in relevance to aqueous titanium(IV)-peroxo-citrate speciation.
    Dakanali M; Kefalas ET; Raptopoulou CP; Terzis A; Voyiatzis G; Kyrikou I; Mavromoustakos T; Salifoglou A
    Inorg Chem; 2003 Jul; 42(15):4632-9. PubMed ID: 12870954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies.
    Sanna D; Ugone V; Pisano L; Serra M; Micera G; Garribba E
    J Inorg Biochem; 2015 Dec; 153():167-177. PubMed ID: 26281973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bis(maltolato)vanadium(III)-polypyridyl complexes: synthesis, characterization, DNA cleavage, and insulin mimetic activity.
    Islam MN; Kumbhar AA; Kumbhar AS; Zeller M; Butcher RJ; Dusane MB; Joshi BN
    Inorg Chem; 2010 Sep; 49(18):8237-46. PubMed ID: 20715814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerobic oxidation of lignin models using a base metal vanadium catalyst.
    Hanson SK; Baker RT; Gordon JC; Scott BL; Thorn DL
    Inorg Chem; 2010 Jun; 49(12):5611-8. PubMed ID: 20491453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.